NatWest Group’s AbbVie ABBV Stock Holding History

NatWest Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-53,216	Closed	-$2.9M	–	129
2015 Q3	$2.9M	Sell	53,216 -3,893	-7%	-$253K	0.07%	130
2015 Q2	$3.84M	Sell	57,109 -4,817	-8%	-$314K	0.05%	122
2015 Q1	$3.63M	Sell	61,926 -104,158	-63%	-$6.29M	0.05%	138
2014 Q4	$10.9M	Sell	166,084 -17,959	-10%	-$1.13M	0.09%	64
2014 Q3	$10.6M	Sell	184,043 -23,512	-11%	-$1.31M	0.09%	71
2014 Q2	$11.7M	Buy	207,555 +2,076	+1%	+$109K	0.49%	57
2014 Q1	$10.6M	Sell	205,479 -98,562	-32%	-$4.98M	0.47%	65
2013 Q4	$16.1M	Buy	304,041 +14,817	+5%	+$728K	0.41%	57
2013 Q3	$12.9M	Sell	289,224 -290,647	-50%	-$12.9M	0.38%	58
2013 Q2	$24M	Buy	+579,871	New	+$25.4M	0.34%	53

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

NatWest Group's ABBV Position: Q4 2015 in Review

NatWest Group sold out of AbbVie (ABBV) in Q4 2015, closing a stake of 53,216 shares — an estimated $2.9M sold.

NatWest Group first reported a position in ABBV in Q2 2013 and held it in 10 quarters. The position peaked at $24M in Q2 2013. 1,637 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

NatWest Group reported no remaining AbbVie position as of Q4 2015 after selling out during the quarter.
NatWest Group sold 53,216 AbbVie shares in Q4 2015, an estimated $2.9M.
NatWest Group first reported a position in AbbVie in Q2 2013 and held it in 10 quarters.
NatWest Group's AbbVie position peaked at $24M in Q2 2013.
1,637 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on NatWest Group's 13F filing for Q4 2015, filed 16 Feb 2016.